Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia

Nature Communications

Volumn 5, Issue , 2014, Pages

  Piazzolla, Daniela ^a   Palla, Adelaida R ^a   Pantoja, Cristina ^a   Cañamero, Marta ^a   De Castro, Ignacio Perez ^a   Ortega, Sagrario ^a   Gómez López, Gonzalo ^a   Dominguez, Orlando ^a   Megías, Diego ^a   Roncador, Giovanna ^a   Luque Garcia, Jose L ^b   Fernandez Tresguerres, Beatriz ^c   Fernandez, Agustin F ^d   Fraga, Mario F ^d,e   Rodriguez Justo, Manuel ^f   Manzanares, Miguel ^c   Sánchez Carbayo, Marta ^g   García Pedrero, Juana María ^d   Rodrigo, Juan P ^d   Malumbres, Marcos ^a   Serrano, Manuel ^a   more..

^a Structural Biology and Biocomputing Programme   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^f UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^g BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; AURKA PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE;

GENE EXPRESSION; GENETIC VARIATION; METHYLATION;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM; EPITHELIUM BASAL CELL; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPERPLASIA; MITOSIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN TARGETING; STRATIFIED EPITHELIUM; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; ENZYMOLOGY; FEMALE; GENETICS; KERATINOCYTE; MALE; METABOLISM; SPECIES DIFFERENCE; TUMOR CELL LINE;

ANIMALS; AURORA KINASE A; CELL LINE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; EPITHELIUM; ESOPHAGUS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MITOSIS; PROMOTER REGIONS, GENETIC; SPECIES SPECIFICITY;

EID: 84903697385     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5226     Document Type: Article

References (65)

1. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 (2007).
2. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 (2007). (Pubitemid 36694189)
3. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003). (Pubitemid 36694188)
4. Wang, S. H., Tsai, M. S., Chiang, M. F. & Li, H. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells. Gene Expr. Patterns 3, 99-103 (2003). (Pubitemid 36358184)
5. Hough, S. R., Clements, I., Welch, P. J. & Wiederholt, K. A. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells 24, 1467-1475 (2006). (Pubitemid 44464663)
6. Hyslop, L. et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23, 1035-1043 (2005). (Pubitemid 41377718)
7. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005). (Pubitemid 41345211)
8. Loh, Y. H. et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440 (2006).
9. Wang, J. et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368 (2006). (Pubitemid 44764111)
10. Chambers, I. & Tomlinson, S. R. The transcriptional foundation of pluripotency. Development 136, 2311-2322 (2009).
11. Gagliardi, A. et al. A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. EMBO J. 32, 2231-2247 (2013).
12. Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319 (2013).
13. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998). (Pubitemid 28507326)
14. Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140 (2003). (Pubitemid 36062514)
15. Gidekel, S., Pizov, G., Bergman, Y. & Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361-370 (2003). (Pubitemid 37491097)
16. Lengner, C. J. et al. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1, 403-415 (2007). (Pubitemid 47506536)
17. Suh, H. et al. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell 1, 515-528 (2007). (Pubitemid 350056408)
18. Arnold, K. et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 9, 317-329 (2011).
19. Bass, A. J. et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 41, 1238-1242 (2009).
20. Gen, Y. et al. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma. Cancer Genet. Cytogenet. 202, 82-93 (2010).
21. Santaliz-Ruiz, L. E. et al. Emerging role of nanog in tumorigenesis and cancer stem cells. Int. J. Cancer doi:10.1002/ijc.28690 (2013).
22. Robertson, M. et al. Nanog retrotransposed genes with functionally conserved open reading frames. Mamm. Genome 17, 732-743 (2006). (Pubitemid 44079944)
23. Booth, H. A. & Holland, P. W. Eleven daughters of NANOG. Genomics 84, 229-238 (2004). (Pubitemid 38834162)
24. Saunders, A., Faiola, F. & Wang, J. Concise review: pursuing self-renewal and pluripotency with the stem cell factor nanog. Stem Cells 31, 1227-1236 (2013).
25. Imamura, M. et al. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev. Biol. 6, 34 (2006).
26. Hattori, N. et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 12, 387-396 (2007). (Pubitemid 46359591)
27. Blelloch, R. et al. Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24, 2007-2013 (2006). (Pubitemid 44477125)
28. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007). (Pubitemid 47080337)
29. Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121, 465-477 (2005). (Pubitemid 40692305)
30. Tanaka, Y., Era, T., Nishikawa, S. & Kawamata, S. Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. Blood 110, 107-115 (2007). (Pubitemid 47026825)
31. Wilson, J. B., Weinberg, W., Johnson, R., Yuspa, S. & Levine, A. J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61, 1315-1327 (1990). (Pubitemid 20208835)
32. Navarro, J. M., Casatorres, J. & Jorcano, J. L. Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J. Biol. Chem. 270, 21362-21367 (1995).
33. Yuspa, S. H. et al. Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis 7, 949-958 (1986).
34. Bornachea, O. et al. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Sci. Rep. 2, 434 (2012).
35. Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521-533 (2008).
36. Lin, T. et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171 (2005). (Pubitemid 40268131)
37. Tsunematsu, T. et al. Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis. Nat. Commun. 4, 1885 (2013).
38. Bischoff, J. R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052-3065 (1998). (Pubitemid 28254378)
39. Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20, 189-193 (1998). (Pubitemid 28455454)
40. Meraldi, P., Honda, R. & Nigg, E. A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 21, 483-492 (2002). (Pubitemid 34174030)
41. Palla, A. R. et al. Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer. Oncogene 33, 2513-2519 (2014).
42. Chiou, S. H. et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14, 4085-4095 (2008).
43. Shimada, Y. et al. Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray. Anticancer Res. 32, 5507-5514 (2012).
44. Du, Y., Shi, L., Wang, T., Liu, Z. & Wang, Z. Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer. J. Cancer Res. Clin. Oncol. 138, 1759-1767 (2012).
45. Tong, T. et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin. Cancer Res. 10, 7304-7310 (2004). (Pubitemid 39487719)
46. Tanaka, E. et al. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 11, 1827-1834 (2005). (Pubitemid 40471846)
47. Yang, S. B. et al. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma. Oncol. Rep. 17, 1083-1088 (2007).
48. Reiter, R. et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res. 12, 5136-5141 (2006). (Pubitemid 44453341)
49. Tabach, Y. et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS ONE 6, e14632 (2011).
50. Badeaux, M. A. et al. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle 12, 2395-2408 (2013).
51. Alcolea, M. P. & Jones, P. H. Tracking cells in their native habitat: lineage tracing in epithelial neoplasia. Nat. Rev. Cancer 13, 161-171 (2013).
52. Doupe, D. P. et al. A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science 337, 1091-1093 (2012).
53. Suva, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567-1570 (2013).
54. Liu, K. et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell 12, 304-315 (2013).
55. Okano, J., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K. & Nakagawa, H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275, 30934-30942 (2000).
56. Gioanni, J. et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol. 24, 1445-1455 (1988).
57. Easty, D. M., Easty, G. C., Carter, R. L., Monaghan, P. & Butler, L. J. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br. J. Cancer 43, 772-785 (1981). (Pubitemid 11071761)
58. Grenman, R. et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67, 2741-2747 (1991).
59. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
60. Mallo, M., Schrewe, H., Martin, J. F., Olson, E. N. & Ohnemus, S. Assembling a functional tympanic membrane: signals from the external acoustic meatus coordinate development of the malleal manubrium. Development 127, 4127-4136 (2000).
61. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005). (Pubitemid 41528093)
62. Yuan, J. S., Reed, A., Chen, F. & Stewart, Jr. C. N. Statistical analysis of real-time PCR data. BMC Bioinformatics 7, 85 (2006).
63. Rodrigo, J. P. et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int. J. Cancer 134, 487-492 (2014).
64. Nishida, N., Nagasaka, T., Kashiwagi, K., Boland, C. R. & Goel, A. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biol. Ther. 6, 525-533 (2007). (Pubitemid 47328326)
65. Festing, M. F. W., Overend, P., Gaines Das, R., Cortina Borja, M. & Berdoy, M. The Design of Animal Experiments. Reducing the Use of Animals in Research Through Better Experimental Design (Royal Society of Medicine Press Limited, 2002).